CELESTIAL

Pankaj Kumar Singh has submitted to the Exchange vide its letter dated April 11, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011.

Dr Jeetainder Roy Gour has submitted to the Exchange vide its letter dated March 31, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Pankaj Kumar Singh has submitted to the Exchange vide its letter dated March 31, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Guidelines, 2011.

Celestial Biolabs Limited has informed the Exchange that the registered office of the Company has been shifted from Plot # 231A, MLA Colony, Road # 12, Banajara Hills, Hyderabad- 500034 to Plot No. 59, Road No. 12, APIIC Tech Park, IDA Nacharam, Hyderabad - 500076 with effect from March 01, 2012, as per the resolution passed by the Board of Directors.

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results along with Limited Review Report for the period ended December 31,2011.

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

Celestial Biolabs Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meting of the company held on September 26, 2011.

Celestial Biolabs Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the members of the Company held on September 26, 2011.

Celestial Biolabs Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 22, 2011 to September 26, 2011 (both days inclusive) for the purpose of Annual General Meeting for the financial year 2010-2011 scheduled to be held on September 26, 2011.

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Celestial Biolabs Limited has informed the Exchange regarding the outcome of Extra Ordinary General Meeting held on April 28, 2011.

Celestial Biolabs Limited has informed the Exchange that the outcome of the meeting of the Board of Directors is as follows : (1) Dr. A. N. Singh has proposed, subject to all necessary approvals, to renounce his entitlement of Sweat Equity Shares for the balance consideration amount of Rs.4.91 crores (towards the transfer of IPRs developed and owned by him to the Company) which is 60% (approx) of his total entitlement of Rs.8.17 crores; (2) To convene an Extraordinary General Meeting of the Company on April 28, 2011 to consider the following : (a) To obtain the consent of the shareholders, su

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

Celestial Biolabs Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/CELESTIAL_lr_24112010.zip.zip target=NEW> For more details click here.</a>

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.

Celestial Biolabs Limited has submitted to the Exchange a copy of the minutes of the Annual General Meeting held on September 30, 2010.

Celestial Biolabs Limited has informed the Exchange that the Board of Directors in their Board meeting concluded on October 6, 2010 have alloted 6,20,000 equity shares of Rs. 10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation (part) for transfer of Intellectual property rights in accordance with SEBI Guidelines.

Celestial Biolabs Limited has informed the Exchange that at the Annual General Meeting of the Company held on September 30, 2010, the following resolution have been passed: 1. Considered & adopted the Audited Accounts of the Company for the financial year ended March 30,2010 and the report of the Board of Directors and Auditor's thereon 2. Re-appointment of Dr. B Siva Kumar as a Director of the Company 3. Re-appointment of Dr. Jeetainder Roy Gaur as a Director of the Company 4. Re-appointment of G.V.Rao & Co., Chartered Accountants, as Auditors of the Company to hold office until the conclusio

Celestial Biolabs Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 27, 2010 to September 30, 2010 (both days inclusive) for the purpose of Annual General Meeting for the financial year 2009-2010 scheduled to be held on September 30, 2010.

Celestial Biolabs Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the period ended June 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/CELESTIAL_LR25082010.zip target=NEW> For more details click here.</a>

Celestial Biolabs Limited has informed the Exchange that "Our Company has started production and marketing of 12 neutraceuticals in the domestic as well as overseas markets. We are glad to confirm that the products were developed through our in-house R & D".

Celestial Biolabs Limited has informed the Exchange that : " we have filed Twelve Patents for Herbal Medicines developed through in-house research facility recognized by Department of Science and Industrial Research, New Delhi ".

Members of the Exchange are hereby informed that the name of Celestial Labs Limited shall be changed to Celestial Biolabs Limited w.e.f. March 17, 2010.

Celestial Labs Limited has informed the Exchange vide its letter dated February 26, 2010 that "The Board of Directors in their just concluded Board meeting held today have allotted 5,89,000 equity shares of Rs.10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation(part) for transfer of Intellectual property rights in accordance with SEBI Guidelines".

Celestial Labs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 25, 2010, have transacted the following business: (1) Allotment of 22,00,000 warrants convertible into equity shares within a period of 18 months at a price of Rs.27/- per warrant in accordance with SEBI Guidelines.

Celestial Labs Limited has informed the Exchange that the name of the Company has been changed from Celestial Labs Limited to Celestial Biolabs Limited w.e.f. December 23, 2009.

Celestial Labs Limited has submitted to the Exchange a copy of the outcome of postal ballot. Further, the Company has informed that all the resolutions were passed with requisite majority as per the report dated December 21, 2009, given by Mr.G.Mohan, Company Secretary, being the Scrutinizer appointed for the purpose. The Result of the Postal Ballot was declared on December 21, 2009, by Dr.A.N.Singh, Chairman & Managing Director of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server

Celestial Labs Limited has informed the Exchange that the members at the Extra Ordinary General Meeting of the Company held on December 14, 2009, inter alia, have passed the following resolutions: 1. Changing the name of the Company from Celestial Labs Ltd. to Celestial Biolabs Ltd. 2. Increasing the Authorised Share Capital from Rs. 14.00 Crores to Rs. 17.00 Crores. 3. Increasing the Borrowing powers of the Board to Rs. 75.00 crores. 4. Issue of Sweat Equity shares in two tranches comprising of 5,89,000 and 6,20,000 equity shares to Dr. A. N. Singh.

Celestial Labs Limited has informed the Exchange regarding the status of utilization of fund as on September 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/CELESTIAL_IPO_27112009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has submitted to the Exchange a copy of the Notice of Postal Ballot along with the Notice of the Extraordinary General Meeting of the members of the Company to be held on December 14, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)<a href=/content/corporate/celestial_notice_24112009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange regarding outcome of the board meeting held on November 06, 2009 - Revised as follows: "In the intimation made to you on 06.11.2009 the number of warrants to be read as 22,00,000 instead of 8,45,000".

Celestial Labs Limited has informed the Exchange regarding the outcome of the meeting of the Board of Directors held on November 06, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Celestial_Outcome_06112009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange that the Board of Directors in their Board Meeting held on October 30, 2009 have transacted the following business : 1) To meet the financial requirements with regard to the expansion plans of the company, the Board has decided to make preferential issue upto 30,00,000 equity shares to Non Promoter/ Others subject to the approval of shareholders and other regulatory bodies. 2) To convene an Extraordinary General Meeting of the members for obtaining their consent for a) Changing the name of the Company from "Celestial Labs Limited" to "Celestial

Celestial Labs Limited has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the Company held on September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/celestial_AGMmin_16102009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange regarding the outcome of Annual General Meeting held on September 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Celestial_AGMOut_30092009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange regarding the status of utilization of fund as on June 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/celestial_utilisation_26082009.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange that the Board of Directors in their meeting held on July 31, 2009 have decided that the Register of Members and Share Transfer Books will remain closed from September 25, 2009 to September 30, 2009 (both days inclusive) for the following purposes: 1) Convening of Annual General Meeting of the Members scheduled to be held on September 30, 2009; and 2) To ascertain the list of members eligible for the Final dividend of Re. 0.50 paise per share (5% on an equity share par value of Rs. 10/-each) if declared by the members in the Annual General Meeti

Celestial Labs Limited has informed the Exchange that the Board of Directors in their just concluded Board meeting held on July 31, 2009 have transacted the following business: 1) The Board of Directors recommended a final dividend of Re. 0.50 paise per share (5% on an equity share par value of Rs. 10/- each). 2) Issue of warrants upto 8,45,000 to Promoters / Promoter Group / Non Promoter / Others.

Celestial Labs Limited has informed the Exchange that the Company has appointed Ms. T A Veena as the Company Secretary of the Company w.e.f. March 16, 2009.

Celestial Labs Limited has informed the Exchange that the Board of Directors of the Company by a resolution passed by circulation has appointed Mr. Subhash C. Srivastava as an Additional Director of the Company w.e.f. April 15, 2009.

Celestial Labs Limited has informed the Exchange that "Celestial has added 50 members Technical team to work in Biopharma - SAP support with an order worth of US $ 1 Million business initially".

Celestial Labs Limited has informed the Exchange regarding the status of utilization of funds as on September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Celestial_Utilisation_22102008.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange that Dr. P.S.N. Reddy has resigned from the Directorship of Company w.e.f. September 15, 2008 as per the resignation letter received from him on September 19, 2008.

Celestial Labs Limited has informed the Exchange that "The members of the company by way of Postal Ballot have passed the Special Resolution under section 79A, 81A of the Companies Act, 1956 in connection with the issue of equity shares as Sweat Equity Shares in lieu of the compensation for the transfer of the ownership rights of the Intellectual property Assets developed and owned by Promoter to the company".

Celestial Labs Limited has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the members of the Company held on August 14, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/CELESTIAL_MINAGM_1709208.zip target=NEW> For more details click here.</a>

Celestial Labs Limited has informed the Exchange that the shareholders of the company at the Annual General Meeting held on August 14, 2008 have accorded necessary approval in respect of the following items placed before the meeting: a) Declaration of equity Dividend of 10% as recommended by Board of Directors. b) Appointment of Sri P.S.N.Reddy and Sri B.Siva Kumar as Directors of the company not liable to retire by rotation. C) Directors Sri Subhash Srivastava and Sri K.C.Sarma retired by rotation And express their unwillingness to be appointed as Directors. d) Re-Appointment of M/s G.V.Rao &

Celestial Labs Limited has informed the Exchange that the Company has been awarded by NSIC / Dun & Brad Street SME rating with SE2A HIGH rating during a recent appraisal done independently.

Celestial Labs Limited has informed the Exchange that : "Celestial Labs Ltd has acquired the contract Research of Rational Laboratories located at Nacharam, Hyderabad and Sandiego, USA. As a part of the agreement Celestial Labs acquires laboratory space of around 48000 sq. feet which substantially enhances the Celestial Labs pitch in Contract Research and Drug Discovery business".

Celestial Labs Limited has informed the Exchange that pursuant to section 192A of the companies Act, 1956 it is proposed to transact the following Special Businesses by the Members of the Company by passing resolutions, as special Resolutions, through Postal Ballot. Resolutions:(1) Issue of 5,89,000 Equity Shares of Rs.10/- each to Dr. Aditya Narayan Singh Promoter, Chairman & Managing Director, during the Financial Year 2008-09.(2) Issue of 6,20,000 Equity Shares of Rs.10/- each to Dr.Aditya Narayan Singh, Promoter, Chairman & Manging Director, during the Financial Year 2009-10. Mr. Anantha

Celestial Labs Limited has informed the Exchange that: "The company has acquired the channel partnership of Microsoft to strengthen Celestial ERP business. The main promoter of the Company, Dr .A.N. Singh is in the process transferring IPR rights worth total 11 crore as valued to the company. However, Dr.A.N.Singh entitlement is 8.175 crore out of which he shall claim worth Rs 2.5 crore shares not exceeding 5% on expended capital, balance will be subsequently claimed. The exercise shall immensely help the company to increase the business in the smaller and medium sectors of ERP business".